Sangamo BioSciences Inc (NASDAQ:SGMO)
| 7.98 Data as of May 24 |  +0.05 / +0.63%Today’s Change | 4.04 Today|||52-Week Range 11.24 | +32.78% Year-to-Date |
Latest SGMO News | Press Releases
No recent news for Sangamo BioSciences Inc.
Today’s Trading
| Previous close | 7.93 |
| Today’s open | 7.96 |
| Day’s range | 7.77 - 8.18 |
| Volume | 468,370 |
| Average volume (3 months) | 834,119 |
| Market cap | $428.9M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/24/2013
Growth & Valuation
| Earnings growth (last year) | +40.85% |
| Earnings growth (this year) | -13.69% |
| Earnings growth (next 5 years) | +24.50% |
| Revenue growth (last year) | +109.86% |
| P/E ratio | NM |
| Price/Sales | 14.64 |
| Price/Book | 6.52 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| QLTIQLT Inc | -0.07 | -0.89% |
| SGYPSynergy Pharmaceutic... | +0.05 | +0.98% |
| AMRIAlbany Molecular Res... | +0.10 | +0.90% |
| DYAXDyax Corp | -0.01 | -0.38% |
Data as of 4:00pm ET, 05/24/2013
Financials
| Next reporting date | July 24, 2013 |
| EPS forecast (this quarter) | -$0.13 |
| Annual revenue (last year) | $21.7M |
| Annual profit (last year) | -$22.3M |
| Net profit margin | -102.81% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Edward O. Lanphier, II |
Chief Financial Officer & Executive Vice President Henry Ward Wolff, MBA, CPA |
Corporate headquarters Richmond, California |
Forecasts
